Heading 4

Frequently Asked Questions (FAQs)

Last updated: August 2026

General Information

1. What is Sidmex Inovia Pvt. Ltd.?

Sidmex Inovia Pvt. Ltd. is a pharmaceutical export and contract manufacturing (CDMO) company founded in 2015 in Ahmedabad, India. We started as Snapdrug.in, a specialty e-pharmacy built to improve access to hard-to-find medicines, and grew through SiNi Pharma Pvt Ltd, our contract generics manufacturing and exports business, into Groupe Sidmex — a group with offices in Ahmedabad and Montréal, Canada. Today we supply branded and specialty pharmaceutical products to buyers in more than 45 countries, including distributors, importers, hospitals, government agencies, and NGOs. The company is registered with IEC number ABNCS9569B and GST number 24ABNCS9569B1ZX, and our products are sourced from WHO-GMP, EU-GMP, and US FDA cGMP certified facilities. Our Canadian presence supports buyers across Europe, Africa, and the Americas, giving importers a single accountable partner for sourcing, quality, documentation, and delivery across multiple markets.

2. What does Sidmex Inovia specialize in?

We specialize in three connected service lines. First, the export and supply of branded pharmaceutical products — specialty, rare, and orphan medicines covering therapeutic areas from oncology and immunology to metabolic and neurological disorders — with ready stock maintained for selected fast-moving brands. Second, contract development and manufacturing (CDMO): formulation development, commercial-scale production, and regulatory-compliant manufacturing at GMP-certified Indian facilities, supporting small, mid, and large volumes. Third, regulatory and technical services: regulatory-ready dossiers in CTD/eCTD format, stability testing under ICH guidelines, pharmacovigilance, and market-expansion support. This combination means a buyer can source finished products and build their own brand with the same partner. With a supply network spanning 45+ countries and dual presence in India and Canada, we handle sourcing, quality, documentation, and logistics under one roof — which is what separates us from plain trading companies.

3. Who are your customers?

Our customers are B2B buyers across the pharmaceutical supply chain: distributors and importers, wholesalers, hospital procurement teams, healthcare institutions, government health agencies, NGOs, and procurement organizations. We do not sell retail or to individual patients. Most buyers come to us because they need a dependable Indian supplier for branded and specialty medicines, or because they want CDMO and private-label support without managing multiple vendors. We serve more than 45 countries, with particular strength in Europe and Africa supported by our Montréal and Ahmedabad offices. Before any order, we confirm the product list, quantities, destination, and documentation requirements, so the shipment arrives complete and compliant. We also guide first-time importers through the documents their country's authorities expect from an Indian exporter, and our documentation package is built to satisfy hospital, government, and NGO tenders.

4. What types of pharmaceutical products do you supply?

Our catalog spans specialty, rare, and orphan medicines across all major therapeutic areas — oncology, immunology, metabolic, neurological, cardiovascular, respiratory, anti-infective, and more. It includes 49 product categories and nearly 10,000 SKUs, with examples like 3 Mune Tablet (oncology), 5 Flucel 250/500 and 5FU GLS 250/500 (chemotherapy), Lefuma 20mg Tablet (antifungal), and Graffalon 100mg Injection (immunotherapy). Every product carries its manufacturer's brand with a unique SKU for clean identification and ordering, and ships in manufacturer-sealed packs with batch numbers and expiry dating. Certificates of analysis are available on request, and all products are manufactured at WHO-GMP, EU-GMP, or US FDA cGMP certified facilities. Because we hold ready stock of selected brands and can source the rest through our manufacturing network, we support both routine repeat orders and one-off specialty requirements with the same documentation standards.

Products & Services

5. Do you maintain ready stock of pharmaceutical products?

Yes. Ready stock of selected branded pharmaceutical products is one of our core strengths. For products in our ready-stock portfolio we can move quickly from confirmed order to dispatch, which matters for buyers running tenders, hospital supply contracts, or restock orders with tight timelines. The ready-stock list covers our fastest-moving brands; products outside it are sourced through our manufacturing network on the same quality and documentation standards. When you send an enquiry, we tell you immediately whether the product is in stock or needs to be sourced, and we give you a realistic delivery window before you commit. Every shipment carries batch numbers and expiry dating, certificates of analysis are available on request, and each order ships with the full documentation set. Speed never comes at the expense of compliance — that balance is the reason hospitals and government buyers continue to reorder through us.

6. Can you source specialty or hard-to-find medicines?

Yes. Our sourcing network is built for hard-to-access products: rare disease drugs, orphan drugs, biologics, oncology treatments, vaccines, and medicines that are unlicensed or unavailable in a buyer's local market. This capability comes from our founding as Snapdrug.in, a specialty e-pharmacy created to improve access to hard-to-find medicines, and it remains central to how we operate today. When a product is not in our catalog or stock, our team identifies qualified manufacturers, verifies the batch, quality, and documentation, and coordinates allocation or production. These products are typically made or reserved to order, so the lead time and minimum quantity are confirmed case by case before you commit. For temperature-sensitive products, shipments are arranged through our cold chain logistics capability, and every export order ships with its full documentation set.

7. Do you offer contract manufacturing (CDMO) services?

Yes. Our CDMO service covers the full arc from development to distribution. We handle formulation development tailored to international market demands, commercial-scale manufacturing at GMP-compliant Indian facilities, and regulatory-compliant production aligned with WHO, GMP, and international guidelines. We are set up for flexibility: small, mid, and large-volume production runs, so emerging brands and established companies can both work with us. As part of the package we can prepare regulatory-ready dossiers in CTD/eCTD format, run stability testing under ICH guidelines, and provide pharmacovigilance services to maintain compliance after launch. With this scope, a company can enter a new market through a single Indian partner — development, manufacturing, documentation, and export distribution — instead of coordinating several suppliers. Faster market launches and a reliable supply line are the practical outcome our CDMO customers measure.

8. Can you support private label or third-party manufacturing?

Yes. We provide private label and third-party manufacturing for selected pharmaceutical products. In practice, we manufacture a product under your brand at a GMP-compliant Indian facility, with your label, packaging, and market-specific artwork, and then manage quality release and export documentation on top. We support the process from product selection and specification through to shipment: formulation where needed, packaging to your market's requirements, and the document set required to register your private-label product in your target market. Private-label projects are arranged product by product — the applicable quantity, packaging configuration, and lead time depend on the manufacturing run and are confirmed in writing before we start. This suits companies that want their own brand in a market without building or managing a factory relationship, and it pairs naturally with our CDMO and dossier services.

Export & International Business

9. Which countries do you export to?

Sidmex Inovia exports to more than 45 countries through a supply network built since our founding in 2015. We are particularly active in Europe and Africa, where our co-founder leads specialty pharma supply growth, and our office in Montréal, Canada strengthens our coverage of the Americas. Product availability and export eligibility depend on the importing country's regulations and the manufacturer's registration for that market, so we confirm compliance for your specific destination before processing an order. For regulated markets we check registration and documentation requirements early; for emerging markets we verify the commercial document set. This per-destination verification is also what makes us reliable for hospital, government, and NGO tenders across multiple countries. Tell us your destination country and product list, and we confirm availability, registration status, and the documentation package in a single response.

10. Do you provide export documentation?

Yes. Every export order ships with the documentation required for international pharmaceutical trade. Commercial documents include the commercial invoice, packing list, and bill of lading or airway bill. Quality and regulatory documents, available on request, include certificates of analysis (CoA), certificates of origin (CoO), free sale certificates, certificates of pharmaceutical product (CPP) where applicable, batch records, and GMP certificates of the manufacturing facility. The documentation set is prepared against your destination country's requirements under our IEC number ABNCS9569B, and is sent in advance or included with the shipment as needed for import clearance. The same package is what hospital, government, and NGO buyers need for tenders — we routinely support this buyer segment, and our documentation standard is consistent whether the order is one line or a full tender list.

11. How can I request a quotation?

Send your enquiry through the Contact Us page — product names, quantities, packaging preferences, and destination country are the four things that let us respond fully. You can also write to us at bd@sidmexinovia.com or call +91 88668 62020; North American buyers can call +1 438 680 1680. Once we receive the details, our team checks stock availability or sourcing feasibility, confirms the documentation requirements for your destination, and returns a complete quotation with pricing, availability, and estimated delivery timing. Our team responds promptly to every enquiry — that is a standing commitment on our contact page. For tender or institutional requirements, share the tender document or specification sheet and we will quote against it. All enquiries are treated as confidential, and nothing is produced or dispatched until the terms are confirmed in writing.

12. Is there a minimum order quantity (MOQ)?

Yes, and it varies by product. The MOQ depends on the manufacturer's production run, the packaging configuration, and the destination country's requirements. Ready-stock products typically carry a lower MOQ because the stock already exists; sourced and manufactured products follow the producing facility's run sizes and are therefore higher. Because quantities are product-specific, we do not publish a blanket number — the applicable MOQ is always stated in the quotation, in writing, before you commit. If you are planning a tender or a phased supply program, tell us the expected volume and timing and we will quote accordingly, including how the quantity breaks down across pack sizes and shipments. The same rule applies to private-label runs: the manufacturing run size defines the starting quantity, and we confirm it before any commitment on either side.

13. What payment terms do you accept?

Payment terms are agreed up front and written into the proforma invoice before production or dispatch begins, so there are no surprises on either side. For international orders we work with the standard methods used in pharmaceutical trade — primarily bank transfer and letters of credit — and we discuss the appropriate arrangement case by case: first orders, repeat business, and institutional or government buyers can be treated differently. Our accounting is based in India with support from our Canadian office, which also simplifies invoicing for North American buyers. Whatever the arrangement, the commercial terms — pricing, payment, incoterms, and delivery window — are confirmed in writing before you commit. If you have a preferred structure, propose it with your enquiry and we will respond with our terms.

14. Which incoterms do you ship on?

We quote on standard international Incoterms, and the applicable term is stated in every quotation and proforma invoice so responsibility for freight, insurance, and customs is clear from the start. In practice, our orders commonly ship on EXW, FOB, or CIF terms from India. If you prefer to manage your own freight, EXW or FOB lets you control the carrier; if you want us to handle freight and insurance through to your port, CIF is the standard arrangement. For door delivery requirements we can discuss the arrangement case by case and confirm what is possible for your destination. Whichever term you choose, the quotation makes the division of responsibility explicit — you will always know what is covered and what is yours to arrange, including cold chain handover points where temperature-controlled products are involved.

15. Do you support import registration or product registration in my country?

Yes. Registering a pharmaceutical product in a new market is exactly the kind of process our regulatory team supports. We prepare regulatory-ready dossiers in CTD/eCTD format for faster approvals, provide stability testing data under ICH guidelines, and assemble the document set your health authority expects — certificates of pharmaceutical product (CPP) where applicable, certificates of analysis, free sale certificates, batch records, and GMP certificates of the manufacturing facility. Because every country's requirements differ, we confirm the exact package for your destination before you start, and we advise on what is needed alongside the registration itself. The same documentation infrastructure underpins our exports to 45+ countries, so the paperwork is routine for us — not something we learn on your project. Tell us the product and target market, and we will outline the document set and the steps involved.

Quality & Compliance

16. How do you ensure product quality?

Quality is controlled at every stage. First, we work only with qualified manufacturing partners — all products are manufactured at WHO-GMP, EU-GMP, or US FDA cGMP certified facilities, and our own processes adhere to EU-GMP, US FDA cGMP, and Health Canada GMP requirements. Second, every batch we supply is accompanied by batch records and, on request, a certificate of analysis from the manufacturer. Third, we verify packaging integrity, batch numbers, and expiry dating before dispatch, and we maintain documented quality assurance procedures for sourcing, storage, and export. Warehousing is WHO-GDP certified, with certificates available on request. Our Canadian and Indian offices together navigate the regulatory requirements of export markets and government tenders. Our full approach is published in our Quality Assurance Policy, and certifications are available on request — the proof is verifiable, not just claimed.

17. Are your products sourced from quality-compliant manufacturers?

Yes. Every product in our catalog is manufactured at WHO-GMP, EU-GMP, or US FDA cGMP certified facilities, and we verify each manufacturer's credentials, batch documentation, and market registration before listing a product. GMP certificates of the manufacturing facility for each product line are available on request, alongside certificates of analysis, batch records, and stability data where applicable. We also maintain WHO-GDP aligned warehousing for the distribution stage — certificates available on request — so the quality chain continues after the product leaves the factory. This end-to-end verification is the same discipline we apply to our own export operations to 45+ countries, where regulated markets inspect the paper trail before products are cleared. For markets with specific registration requirements, we confirm compliance before quoting. In short: the manufacturer's quality standing is checked before the product ever reaches our catalog, and the paperwork to prove it is part of every order.

18. Do you support regulatory documentation?

Yes. Regulatory support is one of our core services. We prepare regulatory-ready dossiers in CTD/eCTD format for faster approvals, run stability testing studies under ICH guidelines to support long-term efficacy claims, and provide pharmacovigilance services to maintain drug safety compliance after launch. For individual shipments, the document set can include certificates of pharmaceutical product (CPP) where applicable, certificates of analysis, free sale certificates, batch records, and GMP certificates of the manufacturing facility. Because requirements differ by country, we confirm the exact documentation package for your destination before you start the import or registration process. This is the same documentation infrastructure that supports our own exports to 45+ countries and government tenders — so when you need papers for a new market, we are not improvising; we are reusing a routine we run daily.

19. Do you support cold-chain (temperature-controlled) shipments?

Yes. Cold chain is part of our standard export capability, not an exception. Our specialty export service explicitly includes cold chain logistics for temperature-sensitive products, and our warehousing is WHO-GDP certified — certificates available on request. Temperature-sensitive medicines, including certain biologics, vaccines, and specialty injectables, are handled through temperature-controlled storage and transport with the monitoring and documentation that confirmation of the cold chain requires. Because cold-chain requirements are product- and route-specific, confirm the product and destination with us before ordering, and we will verify the packaging, route, and monitoring arrangements and state them in the quotation. For buyers running tender or government supply programs with cold-chain lines, this capability is one of the reasons we are chosen as a partner — and it ties directly to our specialty and orphan drug sourcing work.

Orders & Customer Support

20. How long does order processing take?

Order processing time depends on product availability, order quantity, documentation requirements, and destination. For ready-stock products, the fastest path: once the order is confirmed and payment terms are agreed, we move straight to packing, documentation, and dispatch. For sourced or manufactured products, the timeline includes production, quality release, and documentation — longer, but confirmed before you commit. Transit time depends on the destination and shipping method, which we specify at quotation stage. Whatever the route, we give you a delivery window before you order, and we track each shipment until it reaches its destination. If you are working to a tender deadline or a patient-facing supply program, tell us the required date up front and we will tell you honestly whether we can meet it — including a realistic picture of production and cold chain requirements where they apply.

21. How can I contact Sidmex Inovia?

You can reach us through the Contact Us page on this website, by email at bd@sidmexinovia.com, or by phone at +91 88668 62020. North American buyers can also call +1 438 680 1680. Our offices: D-620, Swati Crimson & Clover, Shilaj Cross Road, S.P. Ring Road, Shilaj, Ahmedabad — 380059, Gujarat, India, and 3333 Queen Mary Rd, bureau 108, Montreal, Quebec H3V 1A2, Canada. For the fastest response, include the product names, quantities, and destination country in your enquiry. Our team responds promptly to every message — a standing commitment on our contact page — and enquiries about quotations, tenders, CDMO projects, and partnerships are all treated as confidential. Whether you are a first-time importer or an established buyer, the enquiry process is the same: we confirm details, then answer in one structured response.

22. Why choose Sidmex Inovia?

Four reasons. Availability: ready stock of selected branded products plus a sourcing network for specialty, rare, and orphan medicines — nearly 10,000 SKUs across 49 categories. Compliance: all products manufactured at WHO-GMP, EU-GMP, or US FDA cGMP certified facilities, WHO-GDP certified warehousing, and full export documentation under IEC ABNCS9569B and GST 24ABNCS9569B1ZX. Capability: CDMO and private-label manufacturing with CTD/eCTD dossiers, ICH stability studies, and pharmacovigilance support. Accountability: founded in 2015, serving 45+ countries from offices in Ahmedabad and Montréal, with a single point of contact from enquiry to delivery and terms confirmed in writing before you commit. We are structured for B2B pharmaceutical supply — importers, distributors, hospitals, and procurement agencies — not retail, and our history from e-pharmacy to global export gives us unusual visibility into what patients actually need.

23. Can I request samples before ordering?

Yes. Samples let you verify packaging, batch details, and product presentation before committing to a full order, and we arrange them for selected products — typically those in our ready-stock portfolio. Sample availability depends on the product and the manufacturer, so we confirm what is possible when you request it, along with any sample costs and shipping charges, in writing. For buyers evaluating a supplier, a sample with its certificate of analysis gives you what a photograph cannot: confirmation that the product is exactly what will arrive in a commercial order. The same documentation and quality standards apply to samples as to full shipments. When you are ready to scale, the sample discussion carries straight into the full quotation — same product, same documentation, same accountable point of contact.